登陆
当前位置: 首页 >> 检索结果

结果排序

文献格式

出版时间

出版类型

出版语言
共有 68805 条符合本次的查询结果， 用时 3.1659535 秒

2041. Untitled, Bronx Storefront, "La Rumba Supermarket" : Emilio Sánchez.

作者: Thomas B Cole.
来源: JAMA. 2015年314卷3期210-1页

2042. Advancing Continuing Medical Education.

作者: Graham T McMahon.
来源: JAMA. 2015年314卷6期561-2页

2043. Improving the Quality of Psychosocial Interventions for Mental and Substance Use Disorders: A Report From the IOM.

作者: Harold Alan Pincus.;Mary Jane England.
来源: JAMA. 2015年314卷12期1227-8页

2044. JAMA PATIENT PAGE. Noninvasive Prenatal Testing.

作者: Amy E Thompson.
来源: JAMA. 2015年314卷2期198页

2045. Reinforcements in the Pure Food Crusade.

来源: JAMA. 2015年314卷2期190页

2046. Incorrect Labels in Text and in Table 1 Column Headings.

来源: JAMA. 2015年314卷2期188页

2047. Omission of a Word.

来源: JAMA. 2015年314卷2期188页

2048. Incorrect Date in Figure Title.

来源: JAMA. 2015年314卷2期188页

2049. Incorrect Row Labels in Table 2.

来源: JAMA. 2015年314卷2期188页

2050. Added Sugar Intake and Public Health--Reply.

作者: Nikhil V Dhurandhar.;Diana Thomas.
来源: JAMA. 2015年314卷2期187-8页

2051. Added Sugar Intake and Public Health.

作者: Natalia Linos.;Mary T Bassett.
来源: JAMA. 2015年314卷2期187页

2052. Drug-Drug Interactions in Patients Co-infected With HCV and HIV--Reply.

作者: Anu Osinusi.;Kerry Townsend.;Shyam Kottilil.
来源: JAMA. 2015年314卷2期186-7页

2053. Drug-Drug Interactions in Patients Co-infected With HCV and HIV.

作者: Yuichi Nozaki.;Mikio Yanase.;Naohiko Masaki.
来源: JAMA. 2015年314卷2期186页

2054. State Vaccination Requirements for HPV and Other Vaccines for Adolescents, 1990-2015.

作者: Jason L Schwartz.;Laurel A Easterling.
来源: JAMA. 2015年314卷2期185-6页

2055. Reducing Suicide Risk in Borderline Personality Disorder.

作者: John G Gunderson.
来源: JAMA. 2015年314卷2期181-2页

2056. Polypharmacy in the Aging Patient: Management of Hypertension in Octogenarians.

作者: Athanase Benetos.;Patrick Rossignol.;Antonio Cherubini.;Laure Joly.;Tomasz Grodzicki.;Chakravarthi Rajkumar.;Timo E Strandberg.;Mirko Petrovic.
来源: JAMA. 2015年314卷2期170-80页
Hypertension treatment is beneficial for most hypertensive patients. The benefits for patients who are very old and frail, especially those taking numerous medications, are less certain.

2057. Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease: The AMETHYST-DN Randomized Clinical Trial.

作者: George L Bakris.;Bertram Pitt.;Matthew R Weir.;Mason W Freeman.;Martha R Mayo.;Dahlia Garza.;Yuri Stasiv.;Rezi Zawadzki.;Lance Berman.;David A Bushinsky.; .
来源: JAMA. 2015年314卷2期151-61页
Hyperkalemia is a potentially life-threatening condition predominantly seen in patients treated with renin-angiotensin-aldosterone system (RAAS) inhibitors with stage 3 or greater chronic kidney disease (CKD) who may also have diabetes, heart failure, or both.

2058. Cost-effectiveness of 10-Year Risk Thresholds for Initiation of Statin Therapy for Primary Prevention of Cardiovascular Disease.

作者: Ankur Pandya.;Stephen Sy.;Sylvia Cho.;Milton C Weinstein.;Thomas A Gaziano.
来源: JAMA. 2015年314卷2期142-50页
The American College of Cardiology and the American Heart Association (ACC/AHA) cholesterol treatment guidelines have wide-scale implications for treating adults without history of atherosclerotic cardiovascular disease (ASCVD) with statins.

2059. Guideline-Based Statin Eligibility, Coronary Artery Calcification, and Cardiovascular Events.

作者: Amit Pursnani.;Joseph M Massaro.;Ralph B D'Agostino.;Christopher J O'Donnell.;Udo Hoffmann.
来源: JAMA. 2015年314卷2期134-41页
The 2013 American College of Cardiology/American Heart Association (ACC/AHA) guidelines for cholesterol management defined new eligibility criteria for statin therapy. However, it is unclear whether this approach improves identification of adults at higher risk of cardiovascular events.

2060. Treatment of Hyperkalemia: From "Hyper K+" Strikeout to Home Run?

作者: Wolfgang C Winkelmayer.
来源: JAMA. 2015年314卷2期129-30页
共有 68805 条符合本次的查询结果， 用时 3.1659535 秒